SFE INVESTMENT COUNSEL Cyclo Therapeutics, Inc. Transaction History

SFE INVESTMENT COUNSEL portfolio value:

$0
portfolio value

SFE INVESTMENT COUNSEL quarter portfolio value change:

-33.27%
quarter

Cyclo Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -32.47K shares -354K $7.28 0
Q2 2022 share Decrease -60.51% -49.76K shares -573K $10.91 32.47K
Q1 2022 share Decrease -34.97% -44.21K shares -660K $11.27 82.24K
Q4 2021 share Decrease -42.42% -93.14K shares -1.13M $12.74 126.45K
Q3 2021 share Increase +16.24% 30.67K shares 154K $12.16 219.6K
Q2 2021 share Increase +273.07% 138.28K shares 1.89M $13.06 188.92K
Q1 2021 share Increase 0.00% 50.64K shares 676K $12.61 50.64K